Your Brain Is the Softest Thing in Your Body, that's Why All Implants Are Wrong with Dr. Nicolas Vachicouras

<p>In this episode of the Crux of Neuro, Liz Moyles sits down with Dr. Nicolas Vachicouras, PhD, CEO and Co-Founder of Neurosoft Bioelectronics, a Geneva and New York-based neurotechnology company spun out of EPFL, developing the world&#39;s softest, stretchable brain interfaces.</p><p>Nicolas takes us through his journey from studying the bionic eye, to building brain interfaces for epilepsy, tetraplegics, and severe tinnitus and why the key to all of it starts with matching the mechanical properties of the brain itself.</p><p><br></p><p>KEY TOPICS</p><p>How soft, stretchable electrode materials unlock access to the brain&#39;s hidden 50%</p><p>The minimally invasive deployment method that replaces large craniotomies</p><p>Why Neurosoft chose epilepsy as its beachhead indication and what comes next</p><p>Tinnitus as a neurological condition: 120 million severe cases, and no cure</p><p>Building an objective biomarker for tinnitus and why pharma should be paying attention</p><p>European vs. US investor mindset and why Nicolas is relocating to New York</p><p>The Science Corporation partnership and the Max Hodak mentorship</p><p>What it really means to de-risk a neurotechnology platform before going into humans</p><p><br></p><p>RELATED INSIGHTS</p><p>Why ECoG data collected in epilepsy patients can be used to decode motor intent for tetraplegic BCIs</p><p>The regulatory and reimbursement divergence and why you have to design for both from day one</p><p>Why US investors back vision and team, while European investors demand proof first</p><p>How partnering with Science Corp accelerated Neurosoft&#39;s ASIC and wireless back-end without diluting their core IP</p><p>The case for building your neurotechnology company in the US even if your tech and talent is European</p><p><br></p><p>CORE CHALLENGES</p><p>The brain and spinal cord are extraordinarily soft and constantly in motion yet for decades, we have interfaced with them using rigid, static devices. The resulting mechanical mismatch causes foreign body reaction, device degradation, and limits long-term viability.</p><p>More than 50% of the brain&#39;s cortex sits hidden within its sulci (folds). Existing surface electrode arrays miss most of it and reaching those areas historically requires invasive large-scale craniotomies.</p><p>Severe tinnitus affects 120 million people worldwide, has no cure, and is almost completely misunderstood by the investor community. Objective biomarkers do not yet exist making it h